This content is sponsored by Novo Nordisk. The author attended the conference with assistance from Novo Nordisk.
_{Conflict of interest disclaimers: Dr Jessica Lai has received educational grants from Novo Nordisk. Dr Kiernan Hughes has received advisory board fees, educational travel grants and speak fees from MSD, Sanofi, AstraZeneca, Eli Lilly and Novo Nordisk.}

Watch leading Australian endocrinologists discuss the latest research and scientific outcomes from the recent American Diabetes Association meeting.

In this five-part series, Sydney GP, Dr Peter Piazza interviews Dr Jessica Lai who is based at Liverpool Hospital and Canterbury Hospital, and Dr Kiernan Hughes who has clinical and research roles at St Vincent’s Hospital and the Garvan Institute.

Here, our experts highlight what’s new in insulin therapies including weekly basal insulin, ultra-rapid insulin and inhaled insulin.